Cancer Hospital & Institute, Chinese Academy of Medical Sciences

Slides:



Advertisements
Similar presentations
Neoadjuvant therapy for Rectal cancer
Advertisements

IN THE NAME OF GOD. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy The American Journal.
Advances and Emerging Therapy for Lung Cancer
Adjuvant chemotherapy in resectable liver-limited metastasis colorectal cancer 指導VS: 鄧豪偉 財團法人台灣癌症臨床研究發展基金會.
Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
Borderline Resectable Pancreatic Carcinoma
Management of colorectal cancer with liver metastasis Dr. Vivian Lee Department of Surgery, UCH.
Long-Term Survival Following Hepatectomy for Hepatocellular Carcinoma Sheung Tat FAN Department of Surgery, The University of HongKong Chair Professor.
Joint Hospital Surgical Grand Round 16th Jan 2010 Dr James Fung Department of Surgery United Christian Hospital.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Management of Colorectal Liver Metastasis
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Results of minor and major hepatectomies by laparoscopy Brice Gayet, Vibert E, Kouider A Department of digestive pathology Montsouris Institute, Paris,
Dr. LP Si Tseung Kwan O Hospital. Introduction CA stomach is the 4 th most commonly diagnosed malignancy worldwide 2 nd most common cause of cancer-related.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Outcome Following Limb Salvage Surgery and External Beam Radiotherapy for High Grade Soft Tissue Sarcomas of the Groin and Axilla Rapin Phimolsarnti M.D.
Colorectal Cancer Center Jena Introduction In Germany, there are currently approximately newly diagnosed patients with colorectal carcinoma.
Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.
Management of the Locoregional Recurrence in Well-differentiated Thyroid Carcinoma 陳漢文.
57445 HCC were registered HCC with complete data underwent surgical resection 9577 underwent local ablation therapies 9283 underwent TACE 1150.
Efficacy and Safety of Single Agent Sunitinib in Treating Advanced Hepatocelluar Carcinoma Patients After Sorafenib Failure: A Prospective, Open-Label,
Failure of Treatment in Cervical Cancer Patients *Dr. Zohreh Yousefi fellow ship of gynecology oncology of Mashhad university Fatemeh Homaee, Marzieh.
Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.
The Colorectal Cancer Center Jena Gharbi A, Settmacher U. Department of General, Visceral and Vascular Surgery, Friedrich-Schiller-University Jena
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
Neurology Case Conference 4 PROGNOSIS. Mortality and Morbidity Some patients die with meningioma and not from it Meningiomas usually grow slowly, and.
LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.
EORTC Tumor response to pre-operative chemotherapy (CT) with FOLFOX-4 for resectable colorectal cancer liver metastases (LM) Interim results of the EORTC.
Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Surgery for Metastatic Brain Tumor from Breast Cancer
Adjuvant and Neoadjuvant Therapy in Non- Small Cell Lung Cancer Seminars in Oncology 2oo5;32 (suppl 2):S9-S15 Kyung Hee Medical Center Department of Thoracic.
Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Management of Hepatocellular carcinoma
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer NEJM July vol 359 R2 임규성.
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Debulking in Ovarian Cancer Ashraf Fawzy Nabhan Assistant Prof. of Obstetrics & Gynecology Ain Shams University, Cairo, Egypt.
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy : A Korean multicenter.
Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: Two decades of experience at Chang Gung Memorial Hospital Yi-Yin Jan, Chun-Nan.
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III,
HCC with bile duct tumor thrombi (HCC c BDTT) disease review 1.
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.
PANCREATODUODENECTOMY + MULTIVISCERAL RESECTION YES/NO
Liver surgery for metachronous hepatic metastases with uterine body and uterine cervix origin – a single center experience Nicolae Bacalbasa (1), Irina.
Hepatocellular Carcinoma: Diagnosis and Management
Short-term outcome of neo-adjuvant chemotherapy
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
OPTIMIZING TREATMENT FOR ADVANCED OVARIAN CANCER:
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer:
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
PRESENTATOR: MD VƯƠNG NHẤT PHƯƠNG. HO CHI MINH CITY ONCOLOGY HOSPITAL
高雄長庚 大腸直腸外科 吳昆霖 盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全
Neoadjuvant Adjuvant Curative Palliative
Does Liver Regeneration Increase the Postoperative HCC Recurrence after Curative Resection ? Jin-Ho Lee, MD. Department of Surgery, Yonsei University.
Extended Segmentectomy II to Left Hepatic Vein: Importance of Preserving Umbilical Fissure Vein to Avoid Congestion of Segment III  Kosuke Kobayashi,
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials E Mitry, A Fields,
Survival After Surgical Resection of Stage IV Esophageal Cancer
Bile duct invasion itself can be the prognosis factor in early HCC
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Fig. 2. One case of recurrence out of 12 adult patients with totally resected ependymomas without anaplastic pathology or postoperative adjuvant treatment.
The SUV on 18F-FDG-PET/CT imaging as an independent predictor for overall survival and disease free survival after hepatectomy of Hepatocellular carcinoma(
Prognostic effect of complete pathologic response following TACE on HCC patients undergoing liver resection or transplantation Prognostic effect of complete.
Surgical resection of metachronous liver metastases
Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Group REG Trial Michael Chuong, M.D.1,2, Smith Apisarnthanarx,
Presentation transcript:

Cancer Hospital & Institute, Chinese Academy of Medical Sciences Survival Benefit with IMRT Following Narrow-Margin Hepatectomy in Patients with Hepatocellular Carcinoma Close to Major Vessels Z. Wang, W. Wang, J. Wu, Y. Li Cancer Hospital & Institute, Chinese Academy of Medical Sciences

Background For patients with HCC close to major vessels, potential R1 resections occur frequently (Couinaud segments IV, V and VIII), (Couinaud segments II, III, VI and VII) Our study examines the prognostic significance of postoperative IMRT in patients with narrow-margin (<1.0 cm) hepatectomy

Methods Group A (n = 33) Group B (n = 83) Group C (n = 65) Inclusion criteria Without any neoadjuvant or adjuvant treatments except for postoperative IMRT Macroscopically complete tumor removal Preoperative Child–Pugh class A ECOG Performance Status ≤ 1 Absence of distant metastasis Group A (n = 33) narrow-margin (<1.0 cm) hepatectomy + IMRT surgeons have to carefully dissect and peel the tumor away from the vascular surface because the tumor has adhered to the vessels. Advances in surgical techniques and preoperative planning have led to the development of null-margin (no real resection margin) resections, a special type of R1 resection, where surgeons carefully dissect and peel the tumor away from the vascular surface (14, 15). Null-margin resections of centrally located liver lesions have been reported to be as safe as conventional R0 surgeries Group B (n = 83) narrow-margin hepatectomy alone Group C (n = 65) wide-margin (≥1.0 cm) hepatectomy

Results OS DFS ER (<18 months) Intrahepatic recurrence Extrahepatic recurrence Marginal Nodular Diffuse Group A* 89.1% 64.2% 18.2% 0.0% 30.3% 6.1% 9.1% Group B 67.7% 52.2% 43.4% 9.6% 13.3% 21.7% 20.5% Group C 86.0% 60.1% 16.9% 3.1% 20.0% 9.2% *No patient developed radiation-induced liver disease

Conclusions Postoperative IMRT following narrow-margin hepatectomy may be a favorable therapy for both its clinical benefit and safety profile Moreover, this treatment is equally effective as wide-margin hepatectomy